Results for tag: "Tabimorelin"

Tabimorelin is a drug used to treat endocrine and metabolic disorders. It is a growth hormone secretagogue receptor agonist, meaning it stimulates the release of growth hormone from the pituitary gland. Tabimorelin is used to treat growth hormone deficiency in adults, as well as to diagnose and monitor acromegaly, a condition caused by excessive growth hormone production. It is also used to diagnose and monitor growth hormone deficiency in children. Tabimorelin is available in the form of an oral tablet and is administered once daily. It is generally well tolerated, with the most common side effects being headache, nausea, and dizziness. The Tabimorelin market is a growing segment of the endocrine and metabolic disorders drugs market. It is expected to benefit from the increasing prevalence of endocrine and metabolic disorders, as well as the growing demand for effective treatments. Some companies in the Tabimorelin market include Novo Nordisk, Pfizer, and Eli Lilly. Show Less Read more